Our understanding of virus assembly has practical implications: a new generation of HIV-1 assembly inhibitors acts at the level of particle architecture by reducing the fidelity of the assembly process (Tang et al., 2003) or by blocking connections between Gag proteins (Sticht et al., 2005) .